Comparison between Eastman Auto & Power IPO and Symbiotec Pharmalab IPO.
Eastman Auto & Power IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Symbiotec Pharmalab IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Eastman Auto & Power IPO is up to ₹0.00 Cr whereas the issue size of the Symbiotec Pharmalab IPO is up to ₹2,180.00 Cr. The final issue price of Eastman Auto & Power IPO is and of Symbiotec Pharmalab IPO is .
| Eastman Auto & Power IPO | Symbiotec Pharmalab IPO | |
|---|---|---|
| Face Value | ₹2 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹150.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2,030.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹2,180.00 Cr |
Eastman Auto & Power IPO opens on , while Symbiotec Pharmalab IPO opens on . The closing date of Eastman Auto & Power IPO and Symbiotec Pharmalab IPO is , and , respectively.
Eastman Auto & Power IPO P/E ratio is , as compared to Symbiotec Pharmalab IPO P/E ratio of .
| Eastman Auto & Power IPO | Symbiotec Pharmalab IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials (Restated)Symbiotec Pharmalab Ltd.'s revenue increased by 5% and profit after tax (PAT) dropped by 3% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 34.47 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.66% | ||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.80% | ||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.79% | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Eastman Auto & Power IPO Retail Individual Investors (RII) are offered while in Symbiotec Pharmalab IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Eastman Auto & Power IPO and 0 shares in Symbiotec Pharmalab IPO.
| Eastman Auto & Power IPO | Symbiotec Pharmalab IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Eastman Auto & Power IPO subscribed in total, whereas Symbiotec Pharmalab IPO subscribed .
